🔎 Trials Near Me

Inicio › Enfermedad de Parkinson › Texas

Ensayos clínicos de Enfermedad de Parkinson en Texas

27 estudios sobre Enfermedad de Parkinson buscan participantes en Texas.

Ciudades en Texas

Texto oficial del estudio (inglés)

A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease

  • Site-043, Round Rock
ReclutandoFase 2/3
Edades de 40 a 80 · Todos los sexos · Actualizado el 28 sept 2026 · NCT06976268

A Study of Buntanetap in Participants With PD

  • Central Texas Neurology, Round Rock
ReclutandoFase 2/3
Edades de 40 a 85 · Todos los sexos · Actualizado el 21 sept 2026 · NCT07284784

Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

  • Houston Methodist Research Institute, Houston
  • University of Texas Health Medical Arts and Research Center, San Antonio
  • Texas Institute for Neurological Disorders, Sherman
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 sept 2026 · NCT02071134

Treatment of Cognitive and Sensorimotor Deficits in Parkinson's Disease With High Definition Transcranial Direct Current Stimulation

  • Callier Clinical Center, The University of Texas at Dallas, Richardson
Reclutando
Edades de 50 a 90 · Todos los sexos · Actualizado el 16 sept 2026 · NCT07534397

A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy

  • Vima Site #049, Cypress
  • Vima Site #063, Dallas
  • Vima Site #058, Round Rock
ReclutandoFase 2
Edades de 18 a 65 · Todos los sexos · Actualizado el 11 sept 2026 · NCT07804615

A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations

  • Horizon Clinical Research: Gill Neuroscience - Houston (Site #232), Cypress
  • Central Texas Neurology Consultants (Site #203), Round Rock
ReclutandoFase 2
Edades de 30 a 80 · Todos los sexos · Actualizado el 10 sept 2026 · NCT07432958

Parkinson's Foundation PD GENEration Genetic Registry

  • Baylor College of Medicine, Houston
  • The University of Texas Health Science Center at Houston, Houston
  • University of Texas at San Antonio, San Antonio
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 8 sept 2026 · NCT04994015

A Trial Investigating Lu AF28996 in Adults With Parkinson's Disease Who Have Motor Fluctuations

  • Central Texas Neurology Consultants (CTNC), Round Rock
ReclutandoFase 2
Edades de 40 a 85 · Todos los sexos · Actualizado el 8 sept 2026 · NCT07514858

A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications

  • Baylor College of Medicine, Houston
  • University of Texas Health Science Center at Houston, Houston
ReclutandoEstudio observacional
Edades de 45 a 75 · Todos los sexos · Actualizado el 4 sept 2026 · NCT07330258

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

  • Texas Neurology PA, Dallas
  • Central Texas Neurology Consultants, Round Rock
ReclutandoFase 3
Edades de 50 a 85 · Todos los sexos · Actualizado el 3 sept 2026 · NCT07174310

Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants Earlier Within Advanced Parkinson Disease

  • Texas Movement Disorder Specialists /ID# 278565, Georgetown
ReclutandoEstudio observacional
Edades de 18 a 80 · Todos los sexos · Actualizado el 1 sept 2026 · NCT07227896

A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

  • Neurology Consultants of Dallas PA, Dallas
  • Baylor College of Medicine, Houston
  • The University of Texas Health Science Center at Houston, Houston
  • y 1 más
ReclutandoFase 2
Edades de 40 a 80 · Todos los sexos · Actualizado el 28 ago 2026 · NCT06680830

A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease

  • UTHealth Houston Neurosciences - Texas Medical Center, Houston
ReclutandoFase 3
Edades de 45 a 75 · Todos los sexos · Actualizado el 4 ago 2026 · NCT06944522

PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort

  • Baylor College of Medicine, Houston
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 30 en adelante · Todos los sexos · Actualizado el 27 jul 2026 · NCT04477785

Motor Network Physiology

  • UT Southwestern Medical Center, Dallas
Reclutando
Edades de 18 a 89 · Todos los sexos · Actualizado el 22 jul 2026 · NCT04957095

18F-mFBG Cardiac Uptake With Lewy Body Dementia

  • Houston Methodist Neurological Institute, Houston
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 1 jul 2026 · NCT07176286

A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)

  • Texas Movement Disorder Specialists, Georgetown
  • Houston Methodist (Neurology), Houston
ReclutandoFase 2
Edades de 45 a 75 · Todos los sexos · Actualizado el 29 jun 2026 · NCT06285643

Sensing in Sleep Deep Brain Stimulation

  • The University of Texas Health Science Center at San Antonio - Brain Health Center, San Antonio
Reclutando
Edades de 40 a 80 · Todos los sexos · Actualizado el 9 jun 2026 · NCT07636720

Changes in Movement, Fitness, and Quality of Life in People With Parkinson's Disease After Different Exercise Programs

  • University of Texas at El Paso Doctor of Physical Therapy and Movement Sciences Building, El Paso
  • Move Therapy Services, El Paso
Reclutando
Edades de 50 en adelante · Todos los sexos · Actualizado el 8 may 2026 · NCT07221266

A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease

  • PPD Development, LP, Austin
ReclutandoFase 1Se aceptan voluntarios sanos
Edades de 30 a 85 · Todos los sexos · Actualizado el 20 abr 2026 · NCT06809400

Blood Flow Restriction for Optimizing Balance in Parkinson's Disease

  • University of Texas Health Science Center at San Antonio, San Antonio
Reclutando
Edades de 40 a 85 · Todos los sexos · Actualizado el 31 mar 2026 · NCT06508801

A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications

  • University of Texas Southwestern Medical Center, Dallas
ReclutandoEstudio observacional
Edades de 30 a 99 · Todos los sexos · Actualizado el 20 mar 2026 · NCT05539196

Black and African Americans Connections to Parkinson's Disease (BLAAC PD)

  • University of Texas Health Science Center, Houston, Houston
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 27 feb 2026 · NCT06719583

Facilitating Diagnostics and Prognostics of Parkinsonian Syndromes Using Neuroimaging

  • UT Southwestern Medical Center, Dallas
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Todas las edades · Todos los sexos · Actualizado el 27 ene 2026 · NCT03872102

Action Regulation Behavioral

  • University of Texas Southwestern Medical Center, Dallas
ReclutandoSe aceptan voluntarios sanos
Edades de 18 a 80 · Todos los sexos · Actualizado el 12 dic 2025 · NCT06489483

A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease

  • Neurology Consultants of Dallas, PA, Dallas
  • Texas Movement Disorder Specialists, PLLC, Georgetown
  • Icahn School of Medicine at Mount Sinai, Houston
  • y 1 más
ReclutandoFase 4
Edades de 18 en adelante · Todos los sexos · Actualizado el 24 ago 2025 · NCT06765668

SegwayPD: The Effect of Sensory-augmented Postural Training Using Segway on Motor and Cognitive Function in Individuals With Parkinson's Disease

  • University of Texas Southwestern Medical Center, Dallas
Reclutando
Edades de 50 a 85 · Todos los sexos · Actualizado el 13 ago 2025 · NCT05982730

De ClinicalTrials.gov, datos obtenidos el 30 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.